Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
SpyGlass Pharma, Inc. (SGP) had Cash Flow from Investing Activities of $-2.60M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-19.86M |
|
-- |
|
-- |
|
$21.97M |
|
$-21.97M |
|
$2.10M |
|
$-19.86M |
|
$-19.86M |
|
$-19.86M |
|
$-19.86M |
|
$-19.86M |
|
$-19.86M |
|
$-21.97M |
|
$-21.62M |
|
33.44M |
|
33.44M |
|
$-0.59 |
|
$-0.59 |
|
| Balance Sheet Financials | |
$236.46M |
|
$4.79M |
|
$6.97M |
|
$243.43M |
|
$9.44M |
|
-- |
|
$1.63M |
|
$11.07M |
|
$232.36M |
|
$232.36M |
|
$232.36M |
|
33.45M |
|
| Cash Flow Statement Financials | |
$-28.38M |
|
|
Cash Flow from Investing Activities |
$-2.60M |
$157.77M |
|
$96.36M |
|
$223.14M |
|
$126.78M |
|
$3.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
25.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-30.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.55% |
|
-8.55% |
|
-8.16% |
|
-8.55% |
|
$6.95 |
|
$-0.93 |
|
$-0.85 |
|